DUSP26 and Hip dysplasia: Collectively, the findings of the present study underscore DUSP26 as a promising therapeutic target for DDH‐associated osteoarthritis, offering novel mechanistic insights and laying the groundwork for the development of targeted interventions to mitigate secondary joint degeneration.